Doximity Investor Presentation Deck

THE DIGITAL PLATFORM FOR DOCTORS Leading Network Blue Chip Clients 80%+ 20/20 22% Top Hospitals of all U.S. Physicians¹ and Health Systems Top Pharmaceutical Subscription Revenue Growth5 Manufacturers³ Growth and Profit >525K 118% 45% Net Revenue Retention Rate4 Adj. EBITDA Margin Workflow Unique Active Providers² doximity 5:47 d The Lancet Respiratory Medicine 10 A Atypical Presentation of COVID-19 in a 34 Year- Old Man 22min read-CME The pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) challenges 061 15 Comments Natalia Birgisson, MD Resident Physician 1. As of 6/30/23. 2. For fiscal quarter ending 6/30/23. 3. Top 20 Pharmaceutical Manufacturers based on data from Evaluate, Top 20 hospitals based on U.S. News & World Report's Best Hospitals U.S. News Best Hospitals 2023-2024 Honor Roll. 4. For the trailing twelve month (TTM) period ending 6/30/23. Refer to appendix for the definition of Net Revenue Retention. 5. For the trailing twelve month (TTM) period ending 6/30/23. 6. For the trailing twelve month (TTM) period ending 6/30/23. Refer to appendix for the definition and non-GAAP reconciliation of Adjusted EBITDA and Adjusted EBITDA Margin. I was struck by the multiple possible etiologies explaining his course, and what a reminder more 34-Reply Add a comment Anupam Jena, MD your colleague was published 1d Incremental Health Care Burden of Treatment-Resistant Depression Among Commercial, Medicaid, and Medicare... Psychiatric services (Washington, DC.) Proprietary 3

View entire presentation